Completed PHASE1/PHASE2 INTERVENTIONAL NCT00002873

Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer

A PHASE I/II TRIAL TO EVALUATE BRACHYTHERAPY AS THE SOLE METHOD OF RADIATION THERAPY FOR STAGE I AND II BREAST CARCINOMA

Sponsor: National Cancer Institute (NCI)

Conditions Breast Cancer

Interventions brachytherapy

Updated 6 times since 2017 Last updated: Jul 17, 2013 Started: May 31, 1997 Primary completion: Jun 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00002873, this PHASE1/PHASE2 trial focuses on Breast Cancer and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 6 times since 1997, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

May 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
Radiation Therapy Oncology Group

Data source: Radiation Therapy Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Albany, United States , Albuquerque, United States , Anchorage, United States , Anderson, United States , Ann Arbor, United States , Annapolis, United States , Atlanta, United States , Baltimore, United States , Baton Rouge, United States and 171 more locations